BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38558329)

  • 1. Thyroid nodules with DICER1 mutation or PTEN alteration: A comparative cytologic, clinical, and molecular study of 117 FNA cases.
    Jitpasutham T; Andrianus S; Gubbiotti M; Nosé V; Baloch ZW; Madrigal E; Faquin WC
    Cancer Cytopathol; 2024 Apr; ():. PubMed ID: 38558329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive evaluation of cytomorphologic, histologic, and molecular features of DICER1-altered thyroid lesions on FNA: A multipractice experience.
    Lengyel K; Lubin DJ; Hsiao WY; Sirotnikov S; Luo G; Roberts JW; Shi Q; Magliocca K; Lewis MM; Sears DL; Ilyas G; Rogers BB; Viswanathan K
    Cancer Cytopathol; 2024 Mar; ():. PubMed ID: 38520219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomorphologic features of thyroid disease in patients with DICER1 mutations: A report of cytology-histopathology correlation in 7 patients.
    Darbinyan A; Morotti R; Cai G; Prasad ML; Christison-Lagay E; Dinauer C; Adeniran AJ
    Cancer Cytopathol; 2020 Oct; 128(10):746-756. PubMed ID: 32897650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An institutional experience with DICER1 mutated thyroid nodules-evaluating the cytomorphology and molecular phenotype.
    Lee SH; Vadlamudi C; Zhao Q; Yilmaz O; Cerda S
    J Am Soc Cytopathol; 2022; 11(6):335-344. PubMed ID: 35934646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ThyroSeq v3 for Bethesda III and IV: An institutional experience.
    Desai D; Lepe M; Baloch ZW; Mandel SJ
    Cancer Cytopathol; 2021 Feb; 129(2):164-170. PubMed ID: 33030808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prediction of malignant risk in the category "atypia of undetermined significance/follicular lesion of undetermined significance" of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results.
    Hyeon J; Ahn S; Shin JH; Oh YL
    Cancer Cytopathol; 2014 May; 122(5):368-76. PubMed ID: 24591408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk stratification of cytologically indeterminate thyroid nodules with nondiagnostic or benign cytology on repeat FNA: Implications for molecular testing and surveillance.
    Hall EA; Hartzband P; VanderLaan PA; Nishino M
    Cancer Cytopathol; 2023 May; 131(5):313-324. PubMed ID: 36792948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.
    Dincer N; Balci S; Yazgan A; Guney G; Ersoy R; Cakir B; Guler G
    Cytopathology; 2013 Dec; 24(6):385-90. PubMed ID: 23078633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay.
    Nikiforov YE; Carty SE; Chiosea SI; Coyne C; Duvvuri U; Ferris RL; Gooding WE; Hodak SP; LeBeau SO; Ohori NP; Seethala RR; Tublin ME; Yip L; Nikiforova MN
    Cancer; 2014 Dec; 120(23):3627-34. PubMed ID: 25209362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations.
    Bellevicine C; Sgariglia R; Migliatico I; Vigliar E; D'Anna M; Nacchio MA; Serra N; Malapelle U; Bongiovanni M; Troncone G
    Cancer Cytopathol; 2018 May; 126(5):317-325. PubMed ID: 29469940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined molecular and histologic end points inform cancer risk estimates for thyroid nodules classified as atypia of undetermined significance.
    Onken AM; VanderLaan PA; Hennessey JV; Hartzband P; Nishino M
    Cancer Cytopathol; 2021 Dec; 129(12):947-955. PubMed ID: 34314102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomorphologic features of thyroid nodules harboring thyroid adenoma-associated fusion: A single institutional review of 11 cases.
    Roberts JW; Lubin DJ; Shi Q; Viswanathan K
    Diagn Cytopathol; 2022 Jul; 50(7):327-334. PubMed ID: 35347884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indeterminate Thyroid Fine-Needle Aspirations in Pediatrics: Exploring Clinicopathologic Features and Utility of Molecular Profiling.
    Baran JA; Halada S; Bauer AJ; Ricarte-Filho JC; Isaza A; Surrey LF; McGrath C; Bhatti T; Jalaly J; Mostoufi-Moab S; Franco AT; Adzick NS; Kazahaya K; Cahill AM; Baloch Z
    Horm Res Paediatr; 2022; 95(5):430-441. PubMed ID: 35871517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS).
    Ho AS; Sarti EE; Jain KS; Wang H; Nixon IJ; Shaha AR; Shah JP; Kraus DH; Ghossein R; Fish SA; Wong RJ; Lin O; Morris LG
    Thyroid; 2014 May; 24(5):832-9. PubMed ID: 24341462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suggesting the cytologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): A retrospective analysis of atypical and suspicious nodules.
    Strickland KC; Howitt BE; Barletta JA; Cibas ES; Krane JF
    Cancer Cytopathol; 2018 Feb; 126(2):86-93. PubMed ID: 28914983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant teratomas of the thyroid gland: clinico-radiologic and cytomorphologic features of a rare entity.
    Miller DL; Thompson LDR; Bishop JA; Rooper LM; Ali SZ
    J Am Soc Cytopathol; 2020; 9(4):221-231. PubMed ID: 32448730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on the rate of malignancy for atypia of undetermined significance subcategories.
    Hang JF; Westra WH; Zhou AG; Cooper DS; Ali SZ
    Cancer Cytopathol; 2018 May; 126(5):309-316. PubMed ID: 29424960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology.
    Nikiforov YE; Carty SE; Chiosea SI; Coyne C; Duvvuri U; Ferris RL; Gooding WE; LeBeau SO; Ohori NP; Seethala RR; Tublin ME; Yip L; Nikiforova MN
    Thyroid; 2015 Nov; 25(11):1217-23. PubMed ID: 26356635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of atypia/follicular lesion of undetermined significance: An institutional experience.
    Wong LQ; LiVolsi VA; Baloch ZW
    Cytojournal; 2014; 11():23. PubMed ID: 25210530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid cytology and the risk of malignancy in thyroid nodules: importance of nuclear atypia in indeterminate specimens.
    Kelman AS; Rathan A; Leibowitz J; Burstein DE; Haber RS
    Thyroid; 2001 Mar; 11(3):271-7. PubMed ID: 11327619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.